Zika clone engineered: ‘Critical step in developing a vaccine and antiviral drug’

A multidisciplinary team from The University of Texas Medical Branch at Galveston is the first in the world to genetically engineer a clone of the Zika virus strain, a development that could expedite many aspects of Zika research, including vaccine and therapeutics development. Cloning the virus unlocks scientists' ability to more quickly develop countermeasures and ["]